VeriMom¿Es aesculus hippocastanum fruit powder seguro durante el embarazo?
No EU Annex II (ban) or Annex III (restriction) listing or harmonised CLP reproductive classification was identified for Aesculus hippocastanum (CAS 8053‑39‑2). Authoritative reviews (EMA assessment, NCCIH) state safety in pregnancy/lactation is not established and recommend avoidance for lack of data rather than reporting proven reproductive toxicity; peer‑reviewed reviews of topical cosmetic uses report limited adverse effects (contact dermatitis) but not developmental/reproductive hazards. Thus there is no direct evidence of reproductive hazard, but exposure from topical use is considered low but measurable. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
Related ingredients
Frequently asked questions
- ¿Es aesculus hippocastanum fruit powder seguro durante el embarazo?
- No EU Annex II (ban) or Annex III (restriction) listing or harmonised CLP reproductive classification was identified for Aesculus hippocastanum (CAS 8053‑39‑2). Authoritative reviews (EMA assessment, NCCIH) state safety in pregnancy/lactation is not established and recommend avoidance for lack of data rather than reporting proven reproductive toxicity; peer‑reviewed reviews of topical cosmetic uses report limited adverse effects (contact dermatitis) but not developmental/reproductive hazards. Thus there is no direct evidence of reproductive hazard, but exposure from topical use is considered low but measurable. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
- ¿Es aesculus hippocastanum fruit powder seguro durante la lactancia?
- Same rationale as pregnancy: no harmonised reproductive/CMR classification or EU ban/restriction found; EMA/NCCIH note insufficient data and advise caution. Maternal topical exposure could lead to low but measurable systemic exposure; no infant‑specific toxicity data were found. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
- ¿Es aesculus hippocastanum fruit powder seguro para la piel del bebé?
- No evidence of intrinsic reproductive or developmental toxicity to infants from topical exposure to cosmetic‑grade horse‑chestnut extract. Because baby skin (0–3 yr) has higher permeability and surface‑area‑to‑weight, exposure score is increased by +1 relative to adults (topical adult e=1 → baby e=2). Reports flag contact dermatitis cases but not systemic developmental effects. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18503457/?utm_source=openai))
- ¿Cómo puntúa VeriMom a aesculus hippocastanum fruit powder?
- VeriMom puntúa aesculus hippocastanum fruit powder en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a aesculus hippocastanum fruit powder en el embarazo?
- Consulta nuestra lista de alternativas seguras a aesculus hippocastanum fruit powder según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.